found that increased GAPLINC expression was positively correlated with larger tumor size, advanced tumor stage, and patients shorter survival, and promoted invasion by targeting SNAI2 through binding with PSF and NONO in CRC 25. This evidence concerns the gene SNAI2 and neoplasm.